Gene expression changes in spinal motoneurons of the SOD1(G93A) transgenic model for ALS after treatment with G-CSF

Background: Amyotrophic lateral sclerosis (ALS) is an incurable fatal motoneuron disease with a lifetime risk of approximately 1:400. It is characterized by progressive weakness, muscle wasting, and death ensuing 3–5 years after diagnosis. Granulocyte-colony stimulating factor (G-CSF) is a drug cand...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Cell Neurosci
Autors principals: Henriques, Alexandre, Kastner, Stefan, Chatzikonstantinou, Eva, Pitzer, Claudia, Plaas, Christian, Kirsch, Friederike, Wafzig, Oliver, Krüger, Carola, Spoelgen, Robert, Gonzalez De Aguilar, Jose-Luis, Gretz, Norbert, Schneider, Armin
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2015
Matèries:
Neuroscience
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4299451/
https://ncbi.nlm.nih.gov/pubmed/25653590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2014.00464
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars